What is driving the current price trend for cephalexin monohydrate in China?

What is driving the current price trend for cephalexin monohydrate in China?
Cephalexin monohydrate, a first-generation oral cephalosporin, remains a staple in China's anti-infective market. Recent market signals suggest a stable but competitive environment. Domestic production capacity is concentrated among a few major API manufacturers, and output has been relatively steady. However, upstream raw material costs, particularly for 7-ADCA and side-chain intermediates, have shown slight volatility, influenced by energy and logistics expenses. Downstream demand from formulation makers is moderate, supported by steady hospital and OTC sales. Export orders, especially to Southeast Asia and Africa, provide an additional buffer. Overall, prices are expected to remain range-bound in the near term, with any significant movement likely tied to feedstock cost shifts or environmental inspections affecting production hubs in northern China.